Zogenix reported $155.87M in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acura Pharmaceuticals ACUR:US 404K 33K
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
AstraZeneca AZN:LN 28939M 4338M
Becton, Dickinson and BDX:US $ 17110M 1410M
Biogen BIIB:US $ 6272.3M 996.9M
Cardinal Health CAH:US 5.35B 12M
Esperion Therapeutics ESPR:US $ 272.51M 410K
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
GlaxoSmithKline GSK:LN 20736M 294M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Teva Pharmaceutical TEVA:IT 21.04B 565M
Zogenix ZGNX:US $ 155.87M 2.24M